Microsporum audouinii tinea capitis in a Swiss school: assessment and management of patients and asymptomatic carriers by Donghi, Davide et al.
Medical Mycology April 2011, 49, 324–328 Microsporum audouinii tinea capitis in a Swiss school: 
assessment and management of patients and 
asymptomatic carriers  Received  1  July  2010 ; Recei
Accepted  7  September  2010 
 Correspondence: Philipp P. 
Zurich University Hospital,
Switzerland. Tel:   41 44 2
philipp.bosshard@usz.ch 
 DAVIDE  DONGHI ,   VAL É RIE  HAUSER  &  PHILIPP P.  BOSSHARD 
 Department of Dermatology, University Hospital Zurich, Zurich, Switzerland 
© 2011 ISHAM  We report three cases involving 7- to 8-year-old children from a Swiss school who had 
refractory tinea capitis due to an unusual strain of  Microsporum audouinii which per-
forates hair  in vitro . The patients showed no response to modern oral antifungal drugs 
like terbinafi ne and fl uconazole. After switching to oral griseofulvin, two of the patients 
had a complete recovery, while the third was cured after the introduction of oral itra-
conazole. Given the high potential for contagion of this anthropophilic dermatophyte, 
all family members and three entire school classes were screened using the  ‘ toothbrush 
technique ’ . Three family members and fi ve class-mates were found to be asymptomatic 
carriers of  M. audouinii and were consequently treated to avoid further transmission or 
reinfection of the treated patients. This is the fi rst report of an outbreak of  M. audouinii 
in Switzerland and underlines the importance of screening all contacts of patients with 
 M. audouinii tinea capitis. Further, the effectiveness of griseofulvin in  Microsporum 
tinea capitis has been corroborated, while newer antimycotic drugs like fl uconazole or 
terbinafi ne failed. 
 Keywords  Microsporum audouinii ,  tinea capitis ,  asymptomatic carriers ,  anthropophilic 
dermatophytes ,  griseofulvin  Introduction 
 Microsporum audouinii is an anthropophilic dermatophyte 
common in Africa. It typically causes tinea capitis and 
tinea corporis in children. While  Microsporum canis , a 
zoophilic dermatophyte, is still the most common cause of 
tinea capitis in Europe, an increase in anthropophilic tinea 
capitis has been noted, mainly in urban areas [1]. The 
anthropophilic  Trichophyton tonsurans is the most often 
reported etiologic agent in the UK, whereas  Trichophyton 
soudanense and  M. audouinii are most common in France. 
 M. audouinii cases have also been reported in Italy [2], 
Spain [3] and Portugal [4]. These anthropophilic fungi are 
most prevalent in immigrant communities from Africa and 
Asia. They cause less infl ammatory reactions and have an ved in fi nal revised form 31 August 2010; 
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55 3972; fax:   41 44 255 4418; E-mail: increased tendency to be associated with chronic disease 
as compared to infections due to  M. canis. The latter may 
be the result of late detection due to the absence of subjec-
tive symptoms, even though kerion may occur. 
 Here we describe cases involving three children from 
the same after-school care facility who had tinea capitis 
due to an unusual strain of  M. audouinii . Upon screening, 
eight asymptomatic carriers were found and members of 
this group and the patients were treated. 
 Case report 
 Patient 1 
 In May 2008, an 8-year-old boy of Afghan origin was 
referred to our clinic by his paediatrician because of a 
 persistent (6 months) alopecic patch in the vertex area of 
the scalp with erythematous ground and fi ne scaling. He 
had been treated with oral terbinafi ne at 125 mg daily for 
14 weeks in combination with topical ketoconazole, with-
out clinical improvement. On the fi rst visit to our clinic we DOI: 10.3109/13693786.2010.522602
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We started a 12-week treatment with oral fl uconazole at 35 
mg (1.3 mg/kg) daily in combination with topical econ-
azole. The patient failed to respond clinically and cultures 
inoculated with samples collected 7 and 11 weeks after 
initiation of treatment remained positive for  M. audouinii . 
Fluconazole administration was then changed to pulse 
therapy with 200 mg (8 mg/kg) weekly for 8 weeks. Despite 
this treatment, further analyses conducted during and after 
therapy remained positive. In January 2009, treatment with 
oral griseofulvin was started (20 mg/kg once daily). This 
resulted in rapid clinical improvement and good tolerance, 
and was discontinued after 8 weeks as survey cultures were 
negative. 
 Patient 2 
 An 8-year-old Sri-Lankan boy was referred to us in March 
2008 with the same clinical presentation as patient 1, 
except for a more pronounced scaling in the alopecic patch 
(Fig. 1). The lesion began in October 2007 and an oral (125 
mg daily) and topical treatment with terbinafi ne were initi-
ated in February 2008 by the paediatrician. Mycological 
cultures from patient samples yielded  M. audouinii and led 
to a change of therapy from oral terbinafi ne to oral fl ucon-
azole (50 mg daily, i.e., 2.5 mg/kg), with topical terbinafi ne 
and salicylvaseline. After 10 weeks, fl uconazole was dis-
continued because cultures for the fungus were negative 
and the patient had clinically improved, i.e., scaling and 
erythema had disappeared and hair regrowth had begun. 
Two months later, a clinical relapse was observed and test-
ing again revealed the presence of  M. audouinii . In Sep-
tember 2008, fl uconazole was re-started using a higher 
dose of 120 mg daily (6 mg/kg), but no clinical or myco-
logical improvements were observed over the subsequent 
20 weeks of treatment. Oral griseofulvin (500 mg daily, 
i.e., 20 mg/kg) was started in February 2009 in combina-© 2011 ISHAM, Medical Mycology, 49, 324–328
 tion with topical terbinafi ne and povidone iodine shampoo, 
which resulted in rapid clinical response and in negative 
mycological cultures after 8 weeks of treatment. 
 Patient 3 
 A 7-year-old boy from an Israeli family presented with an 
isolated parietal alopecic area with very discrete, fi ne scal-
ing which had begun in April 2008. Due to the failure of 
topical clotrimazole after 6 months of therapy, the patient 
was referred to our clinic. Culture of plucked hairs revealed 
the presence of  M. audouinii and treatment with oral itra-
conazole was started (200 mg daily) in combination with 
a ciclopirox shampoo. The treatment was discontinued 12 
weeks later after cultures were found to be negative.  
 Mycological analyses 
 Specimens included plucked hairs and skin scrapings from 
the affected area on the scalp. Direct microscopic examina-
tion was performed in a 5% SDS solution containing 
Congo red. Plucked hairs from patient 1 showed an ecto-
thrix type of infection (Fig. 2) and hyphae were found in 
scales of patients 1 and 2. Hairs and scales were inoculated 
onto Sabouraud ’ s dextrose agar with and without chloram-
phenicol and cycloheximide and incubated at room tem-
perature. This resulted in the growth of fl at, transparent, 
and spreading hyphomycete colonies that lacked pigmenta-
tion. Colonies subcultured to potato dextrose agar were 
grayish to skin colored. Upon microscopic examination 
pectinate hyphae and microconidia were observed after 7 
days and macroconidia after 14 days. Macroconidia were 
long, slender and frequently constricted near the middle 
(Fig. 3). After 7 days, urease tests were weakly positive, Fig. 1 Alopecic patch in the vertex area of the scalp with erythematous 
ground and pronounced scaling of an 8-year-old boy (patient 2).  Fig. 2 Direct microscopic examination of hair from patient 1 in 5% SDS 
solution containing Congo red reveals masses of small spores around the 
hair shaft (Ectothrix). 
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casein was noted but no pH change was observed. Based 
on these fi ndings, the isolates were presumptively identi-
fi ed as  M. audouinii . For further confi rmation, hair perfora-
tion tests with blonde pre-pubertal hairs and rice grain 
cultures were performed. Surprisingly, the strain was able 
to perforate hairs after 4 weeks and it grew and sporulated 
on rice grains. Therefore, the internal transcribed spacer 
(ITS) regions of the isolates of patient 1 and 2 were 
sequenced [5] and resulting sequences were compared to 
GenBank with a Blast search. The ITS sequences of the 
isolates were identical to each other and 99.9% identical 
(682/683 identities) to  M. audouinii AJ000622 and 98.7% 
identical (678/687 identities) to  M. canis GU291265, con-
fi rming the identifi cation as  M. audouinii . The sequence 
has been deposited in GenBank (accession number 
HM769946). 
 Epidemiological investigations 
 Due to the contagious potential of  M. audouinii , family 
members of the fi rst two index patients were carefully 
examined and screened for asymptomatic carriage. All 
three patients attended the same after-school care facil-
ity. The school ’ s medical service performed a complete 
screening of all children attending the after-school care 
facility, as well as all the patients ’ class-mates. Screening 
was performed using the toothbrush method [6,7] by 
which different areas of the scalp including frontopari-
etal, temporoparietal, and occipital areas were vigorously 
brushed with a plastic toothbrush. The toothbrushes were 
streaked over Sabouraud ’ s dextrose agar plates contain-
ing chloramphenicol and cycloheximide. The cultures  were then incubated at room temperature for a maximum 
of 4 weeks. Upon clinical examination, family members 
of the patients were asymptomatic. However, samples 
from the father, mother and sister of patient 1 all yielded 
 M. audouinii in culture, i.e., they were asymptomatic car-
riers. They were treated with the same regimen, i.e., oral 
griseofulvin for 8 weeks. Of a total of 95 class mates and 
children of the after-school care facility who were 
screened, fi ve were found to be asymptomatic carriers. 
Of these fi ve children; ( i) all were boys, (ii) three chil-
dren belonged to immigrant families from Africa, one to 
a Tamil family and one was a Swiss boy, (iii) four were 
class-mates of patient 2 (one of which was also in the 
same after-school care facility) and one was a class-mate 
of patient 3. Asymptomatic class mates were treated with 
topical ketoconazole (shampoo) once daily for 4 weeks. 
At this time, no further cases of  M. audouinii tinea capi-
tis have been reported from this school. 
 Discussion 
 The macroscopic, microscopic and physiological features 
of the strain we describe are compatible with  M. audouinii . 
However, the positive hair perforation test (although only 
after 4 weeks) and the relatively good growth and sporula-
tion on rice grains after 2 weeks, are inconsistent with this 
species. The sequence of the internal transcribed spacer 
(ITS) region provided unambiguous evidence that the 
strain was  M. audouinii . We therefore believe that our iso-
late is an unusual strain of  M. audouinii with the ability to 
perforate hairs  in vitro and sporulate on rice grains. 
Recently, the fi rst report concerning a hair perforation-
positive strain of the fungus was published in a German 
case report [8]. 
 While  M. audouinii is most prevalent in Africa, a general 
increase of anthropophilic tinea capitis has been noted in 
Europe [1]. However, few outbreaks with  M. audouinii have 
been described from the developed world in the last years. 
Viguie-Vallanet  et al . reported in 1997 two outbreaks in 
France involving African children [19]. Weill  et al . described 
in 1999 an epidemic in a French school involving 28 cases 
of children of African and European background [20]. 
Haedersdal  et al . reported in 2003 an outbreak of tinea capi-
tis in 12 children at a kindergarten in Denmark originating 
from Danish/African siblings [21]. McPherson  et al . described 
an outbreak of tinea capitis in an English-language school 
in 2008 in Australia involving 23 children who were mostly 
migrants of African or Arab ethnicity. The infections of six 
of the children involved  M. audouinii , with others caused 
by  T. soudanense and T. tonsurans [22]. Interestingly, the 
three patients presented here were from families originat-
ing from South and Western Asia but it is not known where 
the infections originated.  Fig. 3 Microscopic examination of a 14-day-old culture showing macro-
conidia which were long, slender and frequently constricted near the 
middle. © 2011 ISHAM, Medical Mycology, 49, 324–328
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tis because topical antifungals do not penetrate the hair 
follicle [9]. In our three patients, different systemic anti-
mycotics were prescribed along with topical treatment. 
However, patients 1 and 2 were clinically and mycologi-
cally cured through the use of only griseofulvin. Patient 3 
was successfully treated with oral itraconazole. Tradition-
ally, griseofulvin has been the treatment of choice for tinea 
capitis [10] and it is licensed for this application in most 
countries, excluding Switzerland. There is evidence that 
newer antifungals including terbinafi ne, itraconazole and 
fl uconazole may provide similar results as griseofulvin in 
the treatment of tinea capitis caused by  Trichophyton spe-
cies [10]. These antifungals may be preferred because 
shorter duration of treatment may improve adherence. 
While the role of fl uconazole for  Microsporum tinea capi-
tis has not been fully elucidated, itraconazole proved to be 
effective against  Microsporum canis [11,12] with a good 
safety profi le even in the treatment of infants [13]. Unfor-
tunately, effi cacy of itraconazole against  M. audouinii was 
not mentioned in these studies. Terbinafi ne is less effective 
against  Microsporum species as compared to members of 
the genus  Trichophyton [14] and in randomized trials it has 
been shown that there was a better response to griseofulvin 
than to terbinafi ne in patients with infections caused by 
 M. audouinii [15] or  M. canis [16]. Therefore, griseofulvin 
remains the treatment of choice for  Microsporum tinea 
capitis [10]. The paediatric dosage often described is 10 –
 25 mg/kg/day for 6 – 8 weeks [17]. Some patients with 
 Microsporum infections may require longer courses of 
treatment depending on clinical and mycological fi ndings, 
sometimes for as long as 12 weeks [18]. 
 Anthropophilic dermatophytes have been associated 
with high rates of asymptomatic carriage [7]. Most cases 
have been observed in African, African-American, Afri-
can-Caribbean, Anatolian, and Arab populations. The 
majority of reports observed that asymptomatic carriage 
is more common in boys than in girls [7]. This is con-
sistent with our investigation in that of the fi ve class-
mate carriers, three were boys belonging to African 
immigrant families, one was a Tamil boy and one a 
Swiss boy. There is some debate in the literature as to 
whether the spread of anthropophilic infections occurs 
primarily in schools or in households [7]. As all three 
patients of our study attended the same after-school care 
facility, we assume this was the place where transmis-
sion took place, with secondary spread to family mem-
bers. Carriers can become symptomatic themselves. In 
a study following 19 carriers of  M. audouinii [23], 21% 
became symptomatic, 42% had persistent carriage and 
37% became culture-negative after 4 months. Based on 
other reports, Sogair and Hay [18] have estimated 
that approximately 10% of carriers become clinically © 2011 ISHAM, Medical Mycology, 49, 324–328apparent over a 6-month period and that carriers may 
act as vectors in the transmission. For these reasons, 
screening the social environment of index cases is 
important. If possible, all household members of an 
anthropophilic scalp ringworm patient should also be 
examined and screened with the hairbrush or toothbrush 
methods. Additionally, parents should be asked about 
other possibly infected class-mates. It is proposed that 
students in the entire school be screened if more than 
two class-mates are infected [18]. There is no agreement 
on whether carriers should be treated with systemic or 
topical or both types of antifungals or if any form of 
treatment is required [7]. However, as carriers can 
become symptomatic (see above), it seems reasonable 
to treat them. In our experience, topical ketoconazole 
for class-mate carriers effi ciently prevented symptomatic 
infections. 
 The case presented here exemplifi es the high epidemic 
potential of  M. audouinii , reminding us of the importance 
of social environment screening and treatment of asymp-
tomatic carriers. The effectiveness of griseofulvin in 
 Microsporum tinea capitis has been corroborated, while 
newer antimycotic drugs like fl uconazole or terbinafi ne 
failed. For the mycologist, it is important to note that 
 M. audouinii may have the ability to perforate hair  in vitro 
and form conidia on rice grains.  
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